Therefore, SOX10 is an appropriate diagnostic marker to discriminate between CNS_NBL and other CNS-PNET/embryonal tumors but it is not sufficient to distinguish them from GBM_MID (sensitivity—92% and specificity 78% for CNS_NBL). Here, SOX10 is linked to primitive neuroectodermal tumor.